Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Net Income (2022 - 2025)

Historic Net Income for Addex Therapeutics (ADXN) over the last 4 years, with Q2 2025 value amounting to $142225.5.

  • Addex Therapeutics' Net Income fell 9910.28% to $142225.5 in Q2 2025 from the same period last year, while for Sep 2025 it was -$1.5 million, marking a year-over-year decrease of 13717.79%. This contributed to the annual value of $13.6 million for FY2024, which is 25162.55% up from last year.
  • Latest data reveals that Addex Therapeutics reported Net Income of $142225.5 as of Q2 2025, which was down 9910.28% from -$1.6 million recorded in Q1 2025.
  • Addex Therapeutics' 5-year Net Income high stood at $15.9 million for Q2 2024, and its period low was -$9.1 million during Q4 2023.
  • Its 4-year average for Net Income is -$1.1 million, with a median of -$2.2 million in 2023.
  • As far as peak fluctuations go, Addex Therapeutics' Net Income plummeted by 23781.34% in 2023, and later skyrocketed by 76178.03% in 2024.
  • Addex Therapeutics' Net Income (Quarter) stood at $6.6 million in 2022, then crashed by 237.81% to -$9.1 million in 2023, then surged by 99.8% to -$18155.9 in 2024, then surged by 883.36% to $142225.5 in 2025.
  • Its Net Income stands at $142225.5 for Q2 2025, versus -$1.6 million for Q1 2025 and -$18155.9 for Q4 2024.